Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 433

The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.

iACP: a sequence-based tool for identifying anticancer peptides

Open access
Chen, Wei, Ding, Hui, Feng, Pengmian, Lin, Hao, Chou, Kuo-Chen·2016·Oncotarget

Abstract

// Wei Chen 1, 4 , Hui Ding 2 , Pengmian Feng 3 , Hao Lin 2, 4 , Kuo-Chen Chou 4, 5 1 Department of Physics, School of Sciences, Center for Genomics and Computational Biology, North China University of Science and Technology, Tangshan, China 2 Key Laboratory for Neuro-Information of Ministry of Education, Center of Bioinformatics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China 3 School of Public Health, North China University of Science and Technology, Tangshan, China 4 Gordon Life Science Institute, Belmont, Massachusetts, United States of America 5 Center of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University, Jeddah, Saudi Arabia Correspondence to: Wei Chen, e-mail: wchen@gordonlifescience.org , chenweiimu@gmail.com Hao Lin, e-mail: hlin@uestc.edu.cn Kuo-Chen Chou, e-mail: kcchou@gordonlifescience.org Keywords: anticancer peptides, PseAAC, g-gap dipeptide mode, incremental feature selection, iACP webserver Received: January 06, 2016 Accepted: February 11, 2016 Published: March 01, 2016 ABSTRACT Cancer remains a major killer worldwide. Traditional methods of cancer treatment are expensive and have some deleterious side effects on normal cells. Fortunately, the discovery of anticancer peptides (ACPs) has paved a new way for cancer treatment. With the explosive growth of peptide sequences generated in the post genomic age, it is highly desired to develop computational methods for rapidly and effectively identifying ACPs, so as to speed up their application in treating cancer. Here we report a sequence-based predictor called iACP developed by the approach of optimizing the g-gap dipeptide components. It was demonstrated by rigorous cross-validations that the new predictor remarkably outperformed the existing predictors for the same purpose in both overall accuracy and stability. For the convenience of most experimental scientists, a publicly accessible web-server for iACP has been established at http://lin.uestc.edu.cn/server/iACP , by which users can easily obtain their desired results.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.7815

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 133 references

Research works printed but not linked: 19

  1. Castanho, 2013, From antimicrobial to anticancer peptides, Frontiers in microbiology, 4, 294
  2. Chen, 2015, Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs, Mini reviews in medicinal chemistry, 15, 73, 10.2174/1389557514666141107120954 · doi:10.2174/1389557514666141107120954
  3. Du, 2006, Molecular modeling studies of peptide drug candidates against SARS, Medicinal Chemistry, 2, 309, 10.2174/157340606776930736 · doi:10.2174/157340606776930736
  4. Zhong, 2006, Review: Progress in computational approach to drug development against SARS, Current Medicinal Chemistry, 13, 3263, 10.2174/092986706778773077 · doi:10.2174/092986706778773077
  5. Eckhardt, Assessment of the biological and pharmacological effects of the alpha nu beta3 and alpha nu beta5 integrin receptor antagonist, Annals of oncology, 18, 1400
  6. Fee, 1979, Graph theory of enzyme kinetics: 1. Steady-state reaction system, Scientia Sinica, 22, 341
  7. Cornish-Bowden, 1979, Fundamentals of Enzyme Kinetics, Chapter 4
  8. Chou, 1980, A new schematic method in enzyme kinetics, Eur J Biochem, 113, 195, 10.1111/j.1432-1033.1980.tb06155.x · doi:10.1111/j.1432-1033.1980.tb06155.x
  9. Liu, 1981, Graphical rules for non-steady state enzyme kinetics, J Theor Biol, 91, 637, 10.1016/0022-5193(81)90215-0 · doi:10.1016/0022-5193(81)90215-0
  10. Chou, 1989, Graphic rules in steady and non-steady enzyme kinetics, J Biol Chem, 264, 12074, 10.1016/S0021-9258(18)80175-2 · doi:10.1016/s0021-9258(18)80175-2
  11. Shen, 2009, FoldRate: A web-server for predicting protein folding rates from primary sequence, The Open Bioinformatics Journal, 3, 31, 10.2174/1875036200903010031 · doi:10.2174/1875036200903010031
  12. Reusser, 1994, Review: Steady-state inhibition kinetics of processive nucleic acid polymerases and nucleases, Anal Biochem, 221, 217, 10.1006/abio.1994.1405 · doi:10.1006/abio.1994.1405
  13. Forsen, 1981, Graphical rules of steady-state reaction systems, Can J Chem, 59, 737, 10.1139/v81-107 · doi:10.1139/v81-107
  14. Zhang, 1993, Graphic analysis of codon usage strategy in 1490 human proteins, J Protein Chem, 12, 329, 10.1007/BF01028195 · doi:10.1007/bf01028195
  15. Elrod, 1996, Do antisense proteins exist?, J Protein Chem, 15, 59, 10.1007/BF01886811 · doi:10.1007/bf01886811
  16. Chou, 1993, A formulation for correlating properties of peptides and its application to predicting human immunodeficiency virus protease-cleavable sites in proteins, Biopolymers, 33, 1405, 10.1002/bip.360330910 · doi:10.1002/bip.360330910
  17. Zheng, 1995, Neural network prediction of the HIV-1 protease cleavage sites, Journal of Theoretical Biology 177, 369
  18. Mohabatkar, 2014, Predicting anticancer peptides with Chou's pseudo amino acid composition and investigating their mutagenicity via Ames test, J Theor Biol, 341, 34, 10.1016/j.jtbi.2013.08.037 · DOI · Paper page
  19. Xu, 2016, Recent progress in predicting posttranslational modification sites in proteins, Curr Top Med Chem, 16, 591, 10.2174/1568026615666150819110421 · doi:10.2174/1568026615666150819110421

Cited by

Metadata

Authors
Chen, W., Ding, H., Feng, P., Lin, H., & Chou, K.-C.
Venue
Oncotarget
Published
2016-03-01
Volume
7
Issue
13
Pages
16895-16909
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2340970647
Cited by
433
References
133
FWCI
29.34
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.